{"id":12504,"date":"2023-12-15T15:15:00","date_gmt":"2023-12-15T14:15:00","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12504"},"modified":"2026-03-03T10:40:30","modified_gmt":"2026-03-03T09:40:30","slug":"medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/","title":{"rendered":"Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE"},"content":{"rendered":"\n<p class=\"is-style-paragraph-lead-text\">L\u2019Union europ\u00e9enne est, de loin, le principal march\u00e9 d\u2019exportation de la Suisse. Les relations bilat\u00e9rales sont donc capitales pour la place de production et de recherche suisse. Interpharma s\u2019engage depuis des ann\u00e9es pour une solution, nous saluons donc express\u00e9ment le projet de mandat de n\u00e9gociation avec l\u2019Union europ\u00e9enne que le Conseil f\u00e9d\u00e9ral a pr\u00e9sent\u00e9 aujourd\u2019hui.<\/p>\n\n\n\n<p>Avec une part de pr\u00e8s de 40% de l\u2019ensemble des exportations, l\u2019industrie pharmaceutique est la principale branche exportatrice de Suisse. Pr\u00e8s de la moiti\u00e9 de ces exportations vont dans l\u2019Union europ\u00e9enne, de loin le principal march\u00e9 de l\u2019industrie pharmaceutique. La comp\u00e9titivit\u00e9 de la place pharmaceutique suisse d\u00e9pend donc fortement de relations stables et bien r\u00e9gl\u00e9es avec cette partenaire. Le projet de mandat de n\u00e9gociation est une \u00e9tape cruciale vers les \u00abaccords bilat\u00e9raux III\u00bb, importante pour aboutir \u00e0 des relations bien d\u00e9finies et durables avec l\u2019UE.<\/p>\n\n\n\n<p>Ren\u00e9 Buholzer, CEO d\u2019Interpharma, d\u00e9clare \u00e0 ce sujet:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u00abL\u2019histoire \u00e0 succ\u00e8s de l\u2019industrie pharmaceutique se fonde, entre autres, sur des conditions cadres \u00e9conomiques et politiques favorables. Les relations avec notre principale partenaire commerciale, l\u2019UE, sont un \u00e9l\u00e9ment important de l\u2019attractivit\u00e9 de la place suisse. Il est tr\u00e8s r\u00e9jouissant que le Conseil f\u00e9d\u00e9ral entame la prochaine \u00e9tape pour r\u00e9tablir une base solide \u00e0 ces relations.\u00bb<\/em><em><\/em><\/p>\n<\/blockquote>\n\n\n\n<p>Pour l\u2019industrie pharmaceutique, ce sont en particulier l\u2019Accord de reconnaissance mutuelle (ARM), la coop\u00e9ration dans le domaine de la recherche (Horizon Europe) et la libre circulation des personnes qui rev\u00eatent une importance consid\u00e9rable. Ces trois domaines de coop\u00e9ration assurent le libre acc\u00e8s au march\u00e9 int\u00e9rieur de l\u2019UE, la connexion internationale avec les plus \u00e9minent-e-s chercheuses et chercheurs du monde entier et l\u2019acc\u00e8s au personnel sp\u00e9cialis\u00e9 dont nous avons un besoin urgent. 24&nbsp;ans apr\u00e8s la conclusion des accords bilat\u00e9raux&nbsp;I et 19&nbsp;ans apr\u00e8s les accords bilat\u00e9raux&nbsp;II, il est grand temps d\u2019\u00e9claircir les relations de la Suisse avec sa principale partenaire.<\/p>\n\n\n\n<p>Ren\u00e9 Buholzer souligne:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u00abInterpharma s\u2019engage de toutes ses forces pour la stabilisation rapide de la voie bilat\u00e9rale et soutient la direction emprunt\u00e9e par le Conseil f\u00e9d\u00e9ral. Il appartient \u00e0 pr\u00e9sent aux cercles politiques d\u2019entamer rapidement les n\u00e9gociations. Nous avons besoin d\u2019urgence de relations stables et durables avec l\u2019UE, aussi bien pour la recherche que pour l\u2019emploi et pour tout le pays.\u00bb<\/em><em><\/em><\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019Union europ\u00e9enne est, de loin, le principal march\u00e9 d\u2019exportation de la Suisse. Les relations bilat\u00e9rales sont donc capitales pour la place de production et de recherche suisse. Interpharma s\u2019engage depuis des ann\u00e9es pour une solution, nous saluons donc express\u00e9ment le projet de mandat de n\u00e9gociation avec l\u2019Union europ\u00e9enne que le Conseil f\u00e9d\u00e9ral a pr\u00e9sent\u00e9 aujourd\u2019hui. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2828,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[122,130],"class_list":["post-12504","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-communique-de-presse","tag-pharmastandort-2030-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE\" \/>\n<meta property=\"og:description\" content=\"L\u2019Union europ\u00e9enne est, de loin, le principal march\u00e9 d\u2019exportation de la Suisse. Les relations bilat\u00e9rales sont donc capitales pour la place de production et de recherche suisse. Interpharma s\u2019engage depuis des ann\u00e9es pour une solution, nous saluons donc express\u00e9ment le projet de mandat de n\u00e9gociation avec l\u2019Union europ\u00e9enne que le Conseil f\u00e9d\u00e9ral a pr\u00e9sent\u00e9 aujourd\u2019hui. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-15T14:15:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:40:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2023\/04\/CH_EU_generisch-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1731\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE\",\"datePublished\":\"2023-12-15T14:15:00+00:00\",\"dateModified\":\"2026-03-03T09:40:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/\"},\"wordCount\":450,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2023\/04\/CH_EU_generisch-scaled.jpg\",\"keywords\":[\"Communiqu\u00e9 de presse\",\"Pharmastandort 2030\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/\",\"name\":\"Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2023\/04\/CH_EU_generisch-scaled.jpg\",\"datePublished\":\"2023-12-15T14:15:00+00:00\",\"dateModified\":\"2026-03-03T09:40:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2023\/04\/CH_EU_generisch-scaled.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2023\/04\/CH_EU_generisch-scaled.jpg\",\"width\":2560,\"height\":1731},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE","og_description":"L\u2019Union europ\u00e9enne est, de loin, le principal march\u00e9 d\u2019exportation de la Suisse. Les relations bilat\u00e9rales sont donc capitales pour la place de production et de recherche suisse. Interpharma s\u2019engage depuis des ann\u00e9es pour une solution, nous saluons donc express\u00e9ment le projet de mandat de n\u00e9gociation avec l\u2019Union europ\u00e9enne que le Conseil f\u00e9d\u00e9ral a pr\u00e9sent\u00e9 aujourd\u2019hui. [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/","og_site_name":"Interpharma","article_published_time":"2023-12-15T14:15:00+00:00","article_modified_time":"2026-03-03T09:40:30+00:00","og_image":[{"width":2560,"height":1731,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2023\/04\/CH_EU_generisch-scaled.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE","datePublished":"2023-12-15T14:15:00+00:00","dateModified":"2026-03-03T09:40:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/"},"wordCount":450,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2023\/04\/CH_EU_generisch-scaled.jpg","keywords":["Communiqu\u00e9 de presse","Pharmastandort 2030"],"inLanguage":"fr-FR","copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/","name":"Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2023\/04\/CH_EU_generisch-scaled.jpg","datePublished":"2023-12-15T14:15:00+00:00","dateModified":"2026-03-03T09:40:30+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2023\/04\/CH_EU_generisch-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2023\/04\/CH_EU_generisch-scaled.jpg","width":2560,"height":1731},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-eu-verhandlungsmandat-ein-wichtiger-meilenstein-fuer-die-stabilisierung-der-bilateralen-beziehungen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: Bilat\u00e9raux III: une \u00e9tape cruciale pour la stabilisation des relations avec l\u2019UE"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=12504"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12504\/revisions"}],"predecessor-version":[{"id":12505,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12504\/revisions\/12505"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/2828"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=12504"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=12504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}